Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients

Allemani C, Weir HK, Carreira H et al (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet (london, England) 385(9972):977–1010. https://doi.org/10.1016/s0140-6736(14)62038-9

Article  PubMed  Google Scholar 

Arcila ME, Drilon A, Sylvester BE et al (2015) MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking. Clin Cancer Res 21(8):1935–1943. https://doi.org/10.1158/1078-0432.ccr-14-2124

Article  CAS  PubMed  Google Scholar 

Baltanás FC, Pérez-Andrés M, Ginel-Picardo A et al (2013) Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival. Mol Cell Biol 33(22):4562–4578. https://doi.org/10.1128/mcb.01026-13

Article  PubMed  PubMed Central  Google Scholar 

Buch S, Innes H, Lutz PL et al (2022) Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study. Gut. https://doi.org/10.1136/gutjnl-2022-327196

Article  PubMed  Google Scholar 

Carter H, Marty R, Hofree M et al (2017) Interaction landscape of inherited polymorphisms with somatic events in cancer. Cancer Discov 7(4):410–423. https://doi.org/10.1158/2159-8290.cd-16-1045

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng J, Liu C, Liu L et al (2016) MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization. Oncotarget 7(15):20597–20611. https://doi.org/10.18632/oncotarget.7972

Article  PubMed  PubMed Central  Google Scholar 

Cordeddu V, Yin JC, Gunnarsson C et al (2015) Activating mutations affecting the Dbl homology domain of SOS2 cause noonan syndrome. Hum Mutat 36(11):1080–1087. https://doi.org/10.1002/humu.22834

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui X, Zhang A, Liu J, Wu K, Chen Z, Wang Q (2018) Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progression. Biochem Biophys Res Commun 504(4):784–791. https://doi.org/10.1016/j.bbrc.2018.08.076

Article  CAS  PubMed  Google Scholar 

Delire B, Stärkel P (2015) The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications. Eur J Clin Invest 45(6):609–623. https://doi.org/10.1111/eci.12441

Article  CAS  PubMed  Google Scholar 

Demory A, Nault JC (2020) Molecular perspectives for the treatment of hepatocellular carcinoma. Acta Gastro-Enterol Belg 83(2):309–312

CAS  Google Scholar 

Guichard C, Amaddeo G, Imbeaud S et al (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44(6):694–698. https://doi.org/10.1038/ng.2256

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL (2020) ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19(3):1997–2007. https://doi.org/10.3892/etm.2020.8454

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hagihara A, Miyamoto K, Furuta J et al (2004) Identification of 27 5’ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 23(53):8705–8710. https://doi.org/10.1038/sj.onc.1207783

Article  CAS  PubMed  Google Scholar 

He HY, Hu L (2022) Cysteine-rich intestinal protein 1 enhances the progression of hepatocellular carcinoma via Ras signaling. Kaohsiung J Med Sci 38(1):49–58. https://doi.org/10.1002/kjm2.12445

Article  CAS  PubMed  Google Scholar 

Hillig RC, Sautier B, Schroeder J et al (2019) Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction. Proc Natl Acad Sci USA 116(7):2551–2560. https://doi.org/10.1073/pnas.1812963116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu J, Cai D, Zhao Z, Zhong GC, Gong J (2021) Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway. Front Oncol 11:659676. https://doi.org/10.3389/fonc.2021.659676

Article  PubMed  PubMed Central  Google Scholar 

Huang Q (2015) Genetic study of complex diseases in the post-GWAS era. J Genetics Genomics. 42(3):87–98. https://doi.org/10.1016/j.jgg.2015.02.001

Article  CAS  Google Scholar 

Huang WYC, Alvarez S, Kondo Y et al (2019) A molecular assembly phase transition and kinetic proofreading modulate Ras activation by SOS. Science (new York, NY) 363(6431):1098–1103. https://doi.org/10.1126/science.aau5721

Article  CAS  Google Scholar 

Huang Q, Liu Y, Qiu M et al (2022) Potentially functional variants of MAP3K14 in the NF-κB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients. Front Oncol 12:990160. https://doi.org/10.3389/fonc.2022.990160

Article  PubMed  PubMed Central  Google Scholar 

Jannot AS, Ehret G, Perneger T (2015) P < 5 × 10(-8) has emerged as a standard of statistical significance for genome-wide association studies. J Clin Epidemiol 68(4):460–465. https://doi.org/10.1016/j.jclinepi.2015.01.001

Article  PubMed  Google Scholar 

Liu ZK, Shang YK, Chen ZN, Bian H (2017) A three-caller pipeline for variant analysis of cancer whole-exome sequencing data. Mol Med Rep 15(5):2489–2494. https://doi.org/10.3892/mmr.2017.6336

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, Ye J, Khan AA et al (2021) Genome-Wide profiling of alternative splicing signatures associated with prognosis and immune microenvironment of hepatocellular carcinoma. Med Sci Monitor. 27:e930052. https://doi.org/10.12659/msm.930052

Article  CAS  Google Scholar 

Llovet JM, Zucman-Rossi J, Pikarsky E et al (2016) Hepatocellular Carcinoma. Nature Rev Dis Primers 2:16018. https://doi.org/10.1038/nrdp.2016.18

Article  Google Scholar 

Lu P, Chen J, Yan L et al (2019) RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway. Cancer Biol Ther 20(4):435–443. https://doi.org/10.1080/15384047.2018.1529117

Article  CAS  PubMed  Google Scholar 

Ma X, Espana-Serrano L, Kim WJ, Thayele Purayil H, Nie Z, Daaka Y (2014) βArrestin1 regulates the guanine nucleotide exchange factor RasGRF2 expression and the small GTPase Rac-mediated formation of membrane protrusion and cell motility. J Biol Chem 289(19):13638–13650. https://doi.org/10.1074/jbc.M113.511360

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, Zeng S, Zhang Y et al (2017) BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma. Cancer Lett 411:117–129. https://doi.org/10.1016/j.canlet.2017.09.041

Article  CAS  PubMed  Google Scholar 

Moon H, Ro SW (2021) MAPK/ERK signaling pathway in hepatocellular carcinoma. Cancers. https://doi.org/10.3390/cancers13123026

Article  PubMed  PubMed Central  Google Scholar 

Mysore VP, Zhou ZW, Ambrogio C et al (2021) A structural model of a Ras-Raf signalosome. Nat Struct Mol Biol 28(10):847–857. https://doi.org/10.1038/s41594-021-00667-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng H, Zhu E, Wang J et al (2022) RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma. Front Pharmacol 13:989655. https://doi.org/10.3389/fphar.2022.989655

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi F, Qin W, Zhang Y et al (2021) Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. J Exper Clin Cancer Res 40(1):280. https://doi.org/10.1186/s13046-021-02085-4

Article  CAS  Google Scholar 

Sakai H, Shiina I, Shinomiya T, Nagahara Y (2021) BRAP2 inhibits the Ras/Raf/MEK and PI3K/Akt pathways in leukemia cells, thereby inducing apoptosis and inhibiting cell growth. Exp Ther Med 21(5):463. https://doi.org/10.3892/etm.2021.9894

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scheiter A, Evert K, Reibenspies L et al (2022) RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues. Mol Oncol 16(5):1091–1118. https://doi.org/10.1002/1878-0261.13135

Article  CAS  PubMed  Google Scholar 

Sheffels E, Sealover NE, Theard PL, Kortum RL (2021) Anchorage-independent growth conditions reveal a differential SOS2 dependence for transformation and survival in RAS-mutant cancer cells. Small GTPases 12(1):67–78. https://doi.org/10.1080/21541248.2019.1611168

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Sur I, Tuupanen S, Whitington T, Aaltonen LA, Taipale J (2013) Lessons from functional analysis of genome-wide association studies. Can Res 73(14):4180–4184. https://doi.org/10.1158/0008-5472.can-13-0789

Article  CAS  Google Scholar 

Tanaka S, Noguchi N, Ochiai T et al (2007) Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: Rationale for partial hepatectomy as first strategy. J Am Coll Surg 204(1):1–6. https://doi.org/10.1016/j.jamcollsurg.2006.10.004

Article 

留言 (0)

沒有登入
gif